NRX Pharmaceuticals, Inc. Preferred Stock, Shares Issued
NRX Pharmaceuticals, Inc. (NRXP) had Preferred Stock, Shares Issued of 0 shares as of 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Balance Sheet › Equity › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockSharesIssued · last filed 2023-08-14
- 2023-06-30: Preferred Stock, Shares Issued 0.00 shares.
- 2023-03-31: Preferred Stock, Shares Issued 0.00 shares.
- 2022-12-31: Preferred Stock, Shares Issued 0.00 shares.
- 2022-09-30: Preferred Stock, Shares Issued 0.00 shares.
| Period end | Preferred Stock, Shares Issued |
|---|---|
| 2023-06-30 | 0.00 shares 10-Q · filed 2023-08-14 |
| 2023-03-31 | 0.00 shares 10-Q · filed 2023-05-15 |
| 2022-12-31 | 0.00 shares 10-Q · filed 2023-08-14 |
| 2022-09-30 | 0.00 shares 10-Q · filed 2022-11-14 |
| 2022-06-30 | 0.00 shares 10-Q · filed 2022-08-15 |
| 2022-03-31 | 0.00 shares 10-Q · filed 2022-05-16 |
| 2021-12-31 | 0.00 shares 10-K · filed 2023-03-31 |
| 2021-09-30 | 0.00 shares 10-Q/A · filed 2022-08-12 |
| 2021-06-30 | 0.00 shares 10-Q/A · filed 2022-08-12 |
| 2021-03-31 | 0.00 shares 10-Q · filed 2021-05-21 |
| 2020-12-31 | 0.00 shares 10-Q/A · filed 2022-08-12 |
| 2020-09-30 | 0.00 shares 10-Q · filed 2020-11-16 |
| 2020-06-30 | 0.00 shares 10-Q · filed 2020-08-14 |
| 2020-03-31 | 0.00 shares 10-Q · filed 2020-05-15 |
| 2019-12-31 | 0.00 shares 10-K/A · filed 2021-05-14 |
| 2019-09-30 | 0.00 shares 10-Q · filed 2019-11-14 |
| 2019-06-30 | 0.00 shares 10-Q · filed 2019-08-14 |
| 2019-03-31 | 0.00 shares 10-Q · filed 2019-05-15 |
| 2018-12-31 | 0.00 shares 10-K · filed 2020-03-30 |
| 2018-09-30 | 0.00 shares 10-Q · filed 2018-11-08 |
| 2018-06-30 | 0.00 shares 10-Q · filed 2018-08-08 |
| 2018-03-31 | 0.00 shares 10-Q · filed 2018-05-15 |
| 2017-12-31 | 0.00 shares 10-K · filed 2019-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |